Add the costs of these DMSP tasks to your budget proposal!
Briefly describe the scientific data to be managed and shared:
For data subject to the GDS Policy:
- Data types expected to be shared under the GDS Policy should be described in this element. Note that the GDS Policy expects certain types of data to be shared that may not be covered by the DMS Policy’s definition of “scientific data”. For more information on the data types to be shared under the GDS Policy, consult Data Submission and Release Expectations.
Indicate whether specialized tools are needed to access or manipulate shared scientific data to support replication or reuse, and name(s) of the needed tool(s) and software. If applicable, specify how needed tools can be accessed.
Describe what standards, if any, will be applied to the scientific data and associated metadata (i.e., data formats, data dictionaries, data identifiers, definitions, unique identifiers, and other data documentation).
Give plans and timelines for data preservation and access, including:
For data subject to the GDS Policy:
- For human genomic data:
- Investigators are expected to submit data to a repository acceptable under the Genomic Data Sharing Policy. See Where to Submit Genomic Data.
- Human genomic data is expected to be shared according to NIH’s Data Submission and Release Expectations, but no later than the end of the performance period, whichever comes first.
- For Non-human genomic data:
- Investigators may submit data to any widely used repository.
- Non-human genomic data is expected to be shared as soon as possible, but no later than the time of an associated publication, or end of the performance period, whichever is first.
Describe any applicable factors affecting subsequent access, distribution, or reuse of scientific data related to:
Expectations for human genomic data subject to the GDS Policy:
- Informed Consent Expectations:
- For research involving the generation of large-scale human genomic data from cell lines or clinical specimens that were created or collected AFTER the effective date of the GDS Policy (January 25, 2015):
- NIH expects that informed consent for future research use and broad data sharing will have been obtained. This expectation applies to de-identified cell lines or clinical specimens regardless of whether the data meet technical and/or legal definitions of de-identified (i.e. the research does not meet the definition of “human subjects research” under the Common Rule).
- For research involving the generation of large-scale human genomic data from cell lines or clinical specimens that were created or collected BEFORE the effective date of the GDS Policy:
- There may or may not have been consent for research use and broad data sharing. NIH will accept data derived from de-identified cell lines or clinical specimens lacking consent for research use that were created or collected before the effective date of this Policy.
- Institutional Certifications and Data Sharing Limitation Expectations:
- DMS Plans should address limitations on sharing by anticipating sharing according to the criteria of the Institutional Certification.
- In cases where it is anticipated that Institutional Certification criteria cannot be met (i.e., data cannot be shared as expected by the GDS Policy), investigators should state the institutional Certification criteria in their DMS Plan, explaining why the element cannot be met, and indicating what data, if any, can be shared and how to enable sharing to the maximal extent possible (for example, sharing data in a summary format). In some instances, the funding NIH ICO may need to determine whether to grant an exception to the data submission expectation under the GDS Policy.
- Genomic Summary Results:
- Investigators conducting research subject to the GDS Policy should indicate in their DMS Plan if a study should be designated as “sensitive” for the purposes of access to Genomic Summary Results (GSR), as described in NOT-OD-19-023.
Indicate how compliance with the DMS Plan will be monitored and managed, the frequency of oversight, and by whom (e.g., title, roles). This element refers to oversight by the funded institution, rather than by NIH. The DMS Policy does not create any expectations about who will be responsible for Plan oversight at the institution.
The DMS Plan should be submitted as follows:
NIH doesn't endorse or require data sharing in any particular repository. See our Data Repository page of this guide for more information on specific options.
Loyola University Chicago Libraries
Cudahy Library · 1032 W. Sheridan Rd., Chicago, IL 60660 · 773.508.2632
Lewis Library · 25 E. Pearson St., Chicago, IL 60611 · 312.915.6622
Comments & Suggestions
Notice of Non-discriminatory Policy